TriviumVet represented by Susan Kennedy at the information day for SMEs in the veterinary medicines sector organised by European Medicines Agency.

Susan presented TriviumVet’s experience of receiving scientific advice from the EMA. The event gave attendees the opportunity to hear first-hand experience of SME’s and marketing authorisation applications and provided information on the benefits from early dialogue and continuous interaction with EMA during development of innovative veterinary medicines.

TriviumVet work with Texas A&M University on a clinical trial evaluating a new drug – RapaVet® – to treat dilated cardiomyopathy in dogs.

TriviumVet are delighted to be working with Texas A&M University on this exciting clinical trial. Press Release by Texas A&M University: Dilated cardiomyopathy (DCM) is the second most-common acquired cardiac disease in dogs. In its early stage, called the preclinical stage, dogs are apparently healthy to their owners, but beneath the surface, DCM causes a […]